Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-19

Clinical Trial Update: Effectiveness of BufferGel as a Vaginal Contraceptive [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of Phase 2 and Phase 3 studies evaluating BufferGel as a vaginal contraceptive.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BufferGel

Snippet

Sponsor: Premier Research | Conditions: Pregnancy | Phase 2, Phase 3 | Status: COMPLETED